EUVIMEDEUVIMED entdecken
Open Access

TLR4 Inhibition Attenuates Vascular Remodeling in A Mouse Model of Chronic Kidney Disease

Tomohiro Shirouzu, Jun-Ichiro Koga, Nasanbadrakh Orkhonselenge, Yasufumi Nagata, Tetsu Miyamoto, Masaharu Kataoka

Journal of Atherosclerosis and Thrombosis · 2026

DOI: 10.5551/jat.66076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2026. Verfasst von Tomohiro Shirouzu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Department of Internal Medicine, University of Occupational and Environmental Health. Hauptthemen laut MEDLINE: Vascular Remodeling, Toll-Like Receptor 4, Renal Insufficiency, Chronic, Disease Models, Animal. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: Chronic kidney disease (CKD) is linked to accelerated vascular remodeling, characterized by medial thickening and fibrosis; however, the molecular mechanisms driving this process remain unclear. METHODS: We investigated the role of toll-like receptor 4 (TLR4) in CKD-associated vascular remodeling using a 5/6 nephrectomy mouse model. TLR4 signaling was selectively inhibited by the long-term administration of TAK-242, a small-molecule-specific inhibitor of TLR4. RESULTS: TLR4 blockade decreased aortic medial thickening and perivascular fibrosis independent of blood pressure. Immunostaining revealed that blockade of TLR4 decreased Mac-3-positive macrophage accumulation and Ki-67-positive proliferating cells in the aorta. The mRNA expression of IL-6 was suppressed in aortas treated with TAK-242. Disulfide HMGB1 induced the expression of IL-6 in macrophages. Serum from CKD mice induced the expression of IL-6 in RAW264.7 cells and promoted in vitro vascular smooth muscle cell growth, both of which were attenuated with serum from TAK-242-treated CKD mice. CONCLUSION: These findings suggest that TLR4-mediated sterile inflammation may contribute to vascular remodeling in CKD and that modulation of TLR4 signaling could be explored as a potential therapeutic strategy to mitigate cardiovascular complications in CKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular RemodelingToll-Like Receptor 4Renal Insufficiency, ChronicDisease Models, AnimalSulfonamidesAnimalsMiceMaleInterleukin-6MacrophagesMice, Inbred C57BLNephrectomySignal TransductionCell ProliferationRAW 264.7 Cells

Stichwörter der Autor:innen

Chronic kidney diseaseSterile inflammationTAK-242Toll-like receptor 4Vascular remodeling

Substanzen

Toll-Like Receptor 4ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylateInterleukin-6SulfonamidesTlr4 protein, mouse

Autor:innen und Institutionen

  • The Second Department of Internal Medicine, University of Occupational and Environmental Health.
  • Kidney Center, Hospital of the University of Occupational and Environmental Health.

Zitieren

APA

Shirouzu, T., Koga, J. I., Orkhonselenge, N., Nagata, Y., Miyamoto, T., & Kataoka, M. (2026). TLR4 Inhibition Attenuates Vascular Remodeling in A Mouse Model of Chronic Kidney Disease. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.66076

Vancouver

Shirouzu T, Koga JI, Orkhonselenge N, Nagata Y, Miyamoto T, Kataoka M. TLR4 Inhibition Attenuates Vascular Remodeling in A Mouse Model of Chronic Kidney Disease. Journal of Atherosclerosis and Thrombosis. 2026. doi:10.5551/jat.66076

BibTeX
@article{Shirouzu2026,
  author = {Shirouzu, Tomohiro and Koga, Jun-Ichiro and Orkhonselenge, Nasanbadrakh and Nagata, Yasufumi and Miyamoto, Tetsu and Kataoka, Masaharu},
  title = {TLR4 Inhibition Attenuates Vascular Remodeling in A Mouse Model of Chronic Kidney Disease},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  doi = {10.5551/jat.66076}
}
Kostenlos starten →